Hepatosplenic T-Cell Lymphoma: A Rare Complication of Monotherapy with Thiopurines in Crohn’s Disease
Hepatosplenic T-cell lymphoma (HSTCL) is an extremely rare and aggressive form of non-Hodgkin lymphoma associated with poor response to treatment and high mortality. There is an increased incidence among patients with inflammatory bowel disease, especially young male patients under 35 years old and...
Main Authors: | Joana Carvão, Vítor Magno Pereira, Fernando Jacinto, Carla Sousa Andrade, Luís Jasmins |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2018-11-01
|
Series: | GE: Portuguese Journal of Gastroenterology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/493350 |
Similar Items
-
How Does It Look in an Autopsy? Hepatosplenic T-Cell Lymphoma in a Patient with Crohn's Disease on Azathioprine
by: Pulkit Rastogi, et al.
Published: (2020-08-01) -
Efficacy of Thiopurines in Biologic-Naive Japanese Patients With Crohn's Disease: A Single-Center Experience
by: Takuya Yoshino, et al.
Published: (2015-07-01) -
Hypercalcaemia: An Extremely Rare Presentation of Hepatosplenic T-Cell Lymphoma
by: Sara Almeida Ramalho, et al.
Published: (2021-02-01) -
A primary hepatic lymphoma in a patient with Crohn's disease receiving thiopurine and anti-TNF therapy: a case report
by: Salma Merhaben, et al.
Published: (2023-12-01) -
Primary Hepatosplenic Large B-Cell Lymphoma
by: M.R. Morales-Polanco, et al.
Published: (2008-03-01)